Skip to main content
C

ControlPoint

ControlPoint develops diagnostic tools for veterinarians that utilize biomarker analysis to improve pet health assessments. The technology provides accurate and timely diagnostics, enabling veterinarians to make informed treatment decisions for their patients.

Campbell, United StatesFounded 20202200+ followers
Updated 20 months ago

Funding

$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

NS
Funding rounds are not available yet.

Founders

Product

Problem

Veterinarians lack rapid and easy-to-use diagnostic tools for confirming canine respiratory diseases, such as kennel cough, which results in millions of clinic visits annually. Current diagnostic methods can be slow, leading to delays in treatment and potentially impacting patient care. The absence of rapid, point-of-care testing also limits the ability to quickly identify specific pathogens involved in kennel cough infections.

Solution

ControlPoint provides single-use, disposable, handheld diagnostic tests for veterinary clinics, enabling rapid detection of multiple pathogens associated with kennel cough. The K9 Rapid Test delivers results within minutes, allowing veterinarians to quickly address specific conditions and provide timely treatment. Test results can be instantly viewed on the ControlPoint mobile app using a QR code, facilitating easy sharing and access to information. By offering a convenient and accurate point-of-care solution, ControlPoint aims to improve patient outcomes and provide veterinarians with an additional revenue stream.

Target Audience

The primary target audience includes veterinarians and veterinary clinics seeking rapid, point-of-care diagnostic solutions for canine respiratory infections, as well as animal shelters and doggy daycares.

Features

  • Single-use, disposable, handheld test format for easy use in veterinary clinics
  • Rapid results available within minutes, enabling quick treatment decisions
  • Detection of multiple respiratory pathogens with a single test
  • Mobile app integration via QR code for instant viewing and sharing of test results
  • Lateral flow assay technology for accurate and reliable diagnostics
This profile is AI-generated and may contain inaccuracies.